サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ヘルスケアアナリティクス市場の成長機会・産業予測 (2021-2030年)：用途・コンポーネント・展開区分・エンドユーザー・タイプ・地域別
市場調査レポート
商品コード
1032679

ヘルスケアアナリティクス市場の成長機会・産業予測 (2021-2030年)：用途・コンポーネント・展開区分・エンドユーザー・タイプ・地域別

Healthcare Analytics Market by Application, Component, Deployment Model, End User, and Type : Global Opportunity Analysis and Industry Forecast, 2021-2030
出版日: | 発行: Allied Market Research | ページ情報: 英文 308 Pages | 納期: 2～3営業日
AI翻訳ツール 提供対象
ご購入後の翻訳ツール提供について

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=128.03円
ヘルスケアアナリティクス市場の成長機会・産業予測 (2021-2030年)：用途・コンポーネント・展開区分・エンドユーザー・タイプ・地域別
出版日: 2021年08月31日
発行: Allied Market Research
ページ情報: 英文 308 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医療機関におけるビッグデータ導入の増加や、医療機関における電子カルテ（EHR）の導入を促進する政府の取り組みの急増が世界のヘルスケアアナリティクス市場の成長を後押ししています。

また、医療機関の間での支出抑制圧力も市場成長にプラスの影響を与えています。さらに、さまざまな医療機関でクラウドベースのアナリティクスが利用されていることや、医療業界でオーグメンテッドアナリティクスの導入が進んでいることも予測期間中の市場拡大に有益な機会を提供すると考えられています。一方で、導入コストの高さやスキルを有する人材の不足などの要因が市場の成長を妨げると予想されています。

当レポートでは、世界のヘルスケアアナリティクスの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、用途・コンポーネント・展開区分・エンドユーザー・タイプ・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義・範囲
  • ポーターの分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • COVID-19：影響分析

第4章 ヘルスケアアナリティクス市場：用途別

  • 財務分析
  • 運用・管理分析
  • 臨床分析
    • 主要動向・成長要因・機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第5章 ヘルスケアアナリティクス市場：コンポーネント別

  • ハードウェア
  • ソフトウェア
  • サービス
    • 主要動向・成長要因・機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第6章 ヘルスケアアナリティクス市場：展開区分別

  • オンプレミス
  • オンデマンド
    • 主要動向・成長要因・機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第7章 ヘルスケアアナリティクス市場：エンドユーザー別

  • 保険者
  • 医療機関
  • その他
    • 主要動向・成長要因・機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第8章 ヘルスケアアナリティクス市場：タイプ別

  • 記述的アナリティクス
  • 予測的アナリティクス
  • 処方的アナリティクス
    • 主要動向・成長要因・機会
    • 市場規模・予測：地域別
    • 市場分析：国別

第9章 ヘルスケアアナリティクス市場：地域別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ・中東・アフリカ
    • 主要動向・成長要因・機会
    • 市場規模・予測：用途別
    • 市場規模・予測：コンポーネント別
    • 市場規模・予測：展開区分別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：タイプ別
    • 市場規模・予測：国別

第10章 競合情勢

  • 主要企業の位置付け
  • 競合ダッシュボード
  • 主な成功戦略

第11章 企業プロファイル

  • ALLSCRIPTS HEALTHCARE, LLC
  • Cerner Corporation
  • HEALTH CATALYST
  • HMS(VITREOSHEALTH)
  • INTERNATIONAL BUSINESS MACHINES CORPORATION
  • MCKESSON CORPORATION
  • MEDEANALYTICS, INC.
  • OPTUM, INC.
  • ORACLE CORPORATION
  • SAS INSTITUTE INC.
図表

LIST OF TABLES

  • TABLE 01.HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 02.HEALTHCARE ANALYTICS MARKET REVENUE FOR FINANCIAL ANALYSIS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 03.HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYSIS, BY REGION 2020-2030 ($MILLION)
  • TABLE 04.HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYSIS, BY REGION 2020-2030 ($MILLION)
  • TABLE 05.HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 06.HEALTHCARE ANALYTICS MARKET REVENUE FOR HARDWARE, BY REGION, 2020-2030 ($MILLION)
  • TABLE 07.HEALTHCARE ANALYTICS MARKET FOR SOFTWARE, BY REGION 2020-2030 ($MILLION)
  • TABLE 08.HEALTHCARE ANALYTICS MARKET FOR SERVICE, BY REGION 2020-2030 ($MILLION)
  • TABLE 09.HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030($MILLION)
  • TABLE 10.HEALTHCARE ANALYTICS MARKET REVENUE FOR ON-PREMISE, BY REGION, 2020-2030 ($MILLION)
  • TABLE 11.HEALTHCARE ANALYTICS MARKET REVENUE FOR ON-DEMAND, BY REGION, 2020-2030 ($MILLION)
  • TABLE 12.HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030($MILLION)
  • TABLE 13.HEALTHCARE ANALYTICS MARKET REVENUE FOR HEALTHCARE PAYERS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 14.HEALTHCARE ANALYTICS MARKET REVENUE FOR HEALTHCARE PROVIDERS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 15.HEALTHCARE ANALYTICS MARKET REVENUE FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 16.HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030($MILLION)
  • TABLE 17.HEALTHCARE ANALYTICS MARKET REVENUE FOR DESCRIPTIVE ANALYTICS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 18.HEALTHCARE ANALYTICS MARKET REVENUE FOR PREDICTIVE ANALYTICS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 19.HEALTHCARE ANALYTICS MARKET REVENUE FOR PRESCRIPTIVE ANALYTICS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 20.HEALTHCARE ANALYTICS MARKET REVENUE, BY REGION, 2020-2030 ($MILLION)
  • TABLE 21.NORTH AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 22.NORTH AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 23.NORTH AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 24.NORTH AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 25.NORTH AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 26.NORTH AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY COUNTRY, 2020-2028 ($MILLION)
  • TABLE 27.U.S. HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 28.U.S. HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 29.U.S. HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 30.U.S. HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 31.U.S. HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 32.CANADA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 33.CANADA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 34.CANADA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 35.CANADA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 36.CANADA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 37.EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 38.EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 39.EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 40.EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 41.EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 42.EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY COUNTRY, 2020-2028 ($MILLION)
  • TABLE 43.UK HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 44.UK HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 45.UK HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 46.UK HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 47.UK HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 48.GERMANY HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 49.GERMANY HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 50.GERMANY HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 51.GERMANY HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 52.GERMANY HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 53.FRANCE HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 54.FRANCE HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 55.FRANCE HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 56.FRANCE HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 57.FRANCE HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 58.ITALY HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 59.ITALY HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 60.ITALY HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 61.ITALY HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 62.ITALY HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 63.SPAIN HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 64.SPAIN HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 65.SPAIN HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 66.SPAIN HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 67.SPAIN HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 68.NETHERLANDS HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 69.NETHERLANDS HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 70.NETHERLANDS HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 71.NETHERLANDS HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 72.NETHERLANDS HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 73.REST OF EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 74.REST OF EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 75.REST OF EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 76.REST OF EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 77.REST OF EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 78.ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 79.ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 80.ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 81.ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 82.ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 83.ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY COUNTRY, 2020-2028 ($MILLION)
  • TABLE 84.CHINA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 85.CHINA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 86.CHINA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 87.CHINA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 88.CHINA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 89.JAPAN HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 90.JAPAN HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 91.JAPAN HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 92.JAPAN HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 93.JAPAN HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 94.SOUTH KOREA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 95.SOUTH KOREA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 96.SOUTH KOREA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 97.SOUTH KOREA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 98.SOUTH KOREA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 99.AUSTRALIA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 100.AUSTRALIA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 101.AUSTRALIA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 102.AUSTRALIA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 103.AUSTRALIA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 104.INDIA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 105.INDIA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 106.INDIA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 107.INDIA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 108.INDIA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 109.REST OF ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 110.REST OF ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 111.REST OF ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 112.REST OF ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 113.REST OF ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 114.LAMEA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 115.LAMEA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 116.LAMEA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 117.LAMEA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 118.LAMEA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 119.LAMEA HEALTHCARE ANALYTICS MARKET REVENUE, BY COUNTRY, 2020-2028 ($MILLION)
  • TABLE 120.LATIN AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 121.LATIN AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 122.LATIN AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 123.LATIN AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 124.LATIN AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 125.MIDDLE EAST HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 126.MIDDLE EAST HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 127.MIDDLE EAST HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 128.MIDDLE EAST HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 129.MIDDLE EAST HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 130.AFRICA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 131.AFRICA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 132.AFRICA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020-2030 ($MILLION)
  • TABLE 133.AFRICA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020-2030 ($MILLION)
  • TABLE 134.AFRICA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 135.ALLSCRIPTS HEALTHCARE, LLC: KEY EXECUTIVE
  • TABLE 136.ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT
  • TABLE 137.ALLSCRIPTS HEALTHCARE, LLC: OPERATING SEGMENTS
  • TABLE 138.ALLSCRIPTS HEALTHCARE, LLC: PRODUCT PORTFOLIO
  • TABLE 139.CERNER CORPORATION: KEY EXECUTIVES
  • TABLE 140.CERNER CORPORATION: COMPANY SNAPSHOT
  • TABLE 141.CERNER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 142.HEALTH CATALYST: KEY EXECUTIVE
  • TABLE 143.HEALTH CATALYST: COMPANY SNAPSHOT
  • TABLE 144.HEALTH CATALYST: OPERATING SEGMENTS
  • TABLE 145.HEALTH CATALYST: PRODUCT PORTFOLIO
  • TABLE 146.HMS(VITREOSHEALTH): KEY EXECUTIVE
  • TABLE 147.HMS(VITREOSHEALTH): COMPANY SNAPSHOT
  • TABLE 148.HMS(VITREOSHEALTH): PRODUCT PORTFOLIO
  • TABLE 149.INTERNATIONAL BUSINESS MACHINES CORPORATION: KEY EXECUTIVE
  • TABLE 150.INTERNATIONAL BUSINESS MACHINES CORPORATION: COMPANY SNAPSHOT
  • TABLE 151.INTERNATIONAL BUSINESS MACHINES CORPORATION: OPERATING SEGMENTS
  • TABLE 152.INTERNATIONAL BUSINESS MACHINES CORPORATION: PRODUCT PORTFOLIO
  • TABLE 153.MCKESSON CORPORATION.: KEY EXECUTIVES
  • TABLE 154.MCKESSON CORPORATION : COMPANY SNAPSHOT
  • TABLE 155.MCKESSON CORPORATION: OPERATING SEGMENTS
  • TABLE 156.MCKESSON CORPORATION: PRODUCT PORTFOLIO
  • TABLE 157.MEDEANALYTICS, INC.: KEY EXECUTIVES
  • TABLE 158.MEDEANALYTICS, INC.: COMPANY SNAPSHOT
  • TABLE 159.MEDEANALYTICS, INC.: PRODUCT PORTFOLIO
  • TABLE 160.OPTUM, INC.: KEY EXECUTIVES
  • TABLE 161.OPTUM, INC.: COMPANY SNAPSHOT
  • TABLE 162.OPTUM, INC.: PRODUCT PORTFOLIO
  • TABLE 163.ORACLE CORPORATION: KEY EXECUTIVES
  • TABLE 164.ORACLE CORPORATION: COMPANY SNAPSHOT
  • TABLE 165.ORACLE CORPORATION: OPERATING SEGMENTS
  • TABLE 166.ORACLE CORPORATION: PRODUCT PORTFOLIO
  • TABLE 167.ORACLE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 168.SAS INSTITUTE INC.: KEY EXECUTIVE
  • TABLE 169.SAS INSTITUTE INC.: COMPANY SNAPSHOT
  • TABLE 170.SAS INSTITUTE INC.: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.KEY MARKET SEGMENTS
  • FIGURE 02.HEALTHCARE ANALYTICS MARKET SNAPSHOT, BY SEGMENTATION, 2020-2030
  • FIGURE 03.HEALTHCARE ANALYTICS MARKET SNAPSHOT, BY COUNTRY, 2020-2030
  • FIGURE 04.TOP IMPACTING FACTORS
  • FIGURE 05.TOP INVESTMENT POCKETS
  • FIGURE 06.MODERATE -TO-HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 07.MODERATE-TO-HIGH BARGAINING POWER OF BUYER
  • FIGURE 08.MODERATE THREAT OF SUBSTITUTES
  • FIGURE 09.MODERATE-TO-HIGH THREAT OF NEW ENTRANTS
  • FIGURE 10.MODERATE-TO-HIGH COMPETITIVE RIVALRY
  • FIGURE 11.HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
  • FIGURE 12.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE ANALYTICS MARKET FOR FINANCIAL ANALYSIS, BY COUNTRY, 2020 & 2030(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS FOR HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYSIS, BY COUNTRY, 2020 & 2030(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS FOR HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYSIS, BY COUNTRY, 2020 & 2030(%)
  • FIGURE 15.HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020-2030 ($MILLION)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE ANALYTICS MARKET FOR HARDWARE, BY COUNTRY, 2020 & 2030(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS FOR HEALTHCARE ANALYTICS MARKET FOR SOFTWARE, BY COUNTRY, 2020 & 2030(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS FOR HEALTHCARE ANALYTICS MARKET FOR SERVICES, BY COUNTRY, 2020 & 2030(%)
  • FIGURE 19.HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL, 2020-2030
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE ANALYTICS MARKET FOR ON-PREMISE, BY COUNTRY, 2020 & 2030(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE ANALYTICS MARKET FOR ON-DEMAND, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 22.HEALTHCARE ANALYTICS MARKET, BY END USER, 2020-2030
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2020 & 2030(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2020 & 2030(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE ANALYTICS MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 26.HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020-2030
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE ANALYTICS MARKET FOR DESCRIPTIVE ANALYTICS, BY COUNTRY, 2020 & 2030(%)
  • FIGURE 28.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE ANALYTICS MARKET FOR PREDICTIVE ANALYTICS, BY COUNTRY, 2020 & 2030(%)
  • FIGURE 29.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE ANALYTICS MARKET FOR PRESCRIPTIVE ANALYTICS, BY COUNTRY, 2020 & 2030(%)
  • FIGURE 30.U.S. HEALTHCARE ANALYTICS MARKET REVENUE, 2020-2030 ($MILLION)
  • FIGURE 31.CANADA HEALTHCARE ANALYTICS MARKET REVENUE, 2020-2030 ($MILLION)
  • FIGURE 32.UK HEALTHCARE ANALYTICS MARKET REVENUE, 2020-2030 ($MILLION)
  • FIGURE 33.GERMANY HEALTHCARE ANALYTICS MARKET REVENUE, 2020-2030 ($MILLION)
  • FIGURE 34.FRANCE HEALTHCARE ANALYTICS MARKET REVENUE, 2020-2030 ($MILLION)
  • FIGURE 35.ITALY HEALTHCARE ANALYTICS MARKET REVENUE, 2020-2030 ($MILLION)
  • FIGURE 36.SPAIN HEALTHCARE ANALYTICS MARKET REVENUE, 2020-2030 ($MILLION)
  • FIGURE 37.NETHERLANDS HEALTHCARE ANALYTICS MARKET REVENUE, 2020-2030 ($MILLION)
  • FIGURE 38.REST OF EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, 2020-2030 ($MILLION)
  • FIGURE 39.CHINA HEALTHCARE ANALYTICS MARKET REVENUE, 2020-2030 ($MILLION)
  • FIGURE 40.JAPAN HEALTHCARE ANALYTICS MARKET REVENUE, 2020-2030 ($MILLION)
  • FIGURE 41.SOUTH KOREA HEALTHCARE ANALYTICS MARKET REVENUE, 2020-2030 ($MILLION)
  • FIGURE 42.AUSTRALIA HEALTHCARE ANALYTICS MARKET REVENUE, 2020-2030 ($MILLION)
  • FIGURE 43.INDIA HEALTHCARE ANALYTICS MARKET REVENUE, 2020-2030 ($MILLION)
  • FIGURE 44.REST OF ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, 2020-2030 ($MILLION)
  • FIGURE 45.LATIN AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, 2020-2030 ($MILLION)
  • FIGURE 46.MIDDLE EAST HEALTHCARE ANALYTICS MARKET REVENUE, 2020-2030 ($MILLION)
  • FIGURE 47.AFRICA HEALTHCARE ANALYTICS MARKET REVENUE, 2020-2030 ($MILLION)
  • FIGURE 48.KEY PLAYER POSITIONING ANLYSIS: GLOBAL HEALTHCARE ANALYTICS MARKET
  • FIGURE 49.COMPETITIVE DASHBOARD
  • FIGURE 50.COMPETITIVE DASHBOARD
  • FIGURE 51.COMPETITIVE HEATMAP OF KEY PLAYERS
  • FIGURE 52.TOP WINNING STRATEGIES, BY YEAR, 2019-2021
  • FIGURE 53.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021
  • FIGURE 54.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021
  • FIGURE 55.R&D EXPENDITURE, 2018-2020 ($MILLION)
  • FIGURE 56.ALLSCRIPTS HEALTHCARE, LLC: REVENUE, 2018-2020 ($MILLION)
  • FIGURE 57.ALLSCRIPTS HEALTHCARE, LLC: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 58.ALLSCRIPTS HEALTHCARE, LLC: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 59.CERNER CORPORATION: REVENUE, 2018-2020 ($MILLION)
  • FIGURE 60.R&D EXPENDITURE, 2018-2020 ($MILLION)
  • FIGURE 61.HEALTH CATALYST: REVENUE, 2018-2020 ($MILLION)
  • FIGURE 62.HEALTH CATALYST: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 63.HMS(VITREOSHEALTH): REVENUE, 2018-2020 ($MILLION)
  • FIGURE 64.R&D EXPENDITURE, 2018-2020 ($MILLION)
  • FIGURE 65.INTERNATIONAL BUSINESS MACHINES CORPORATION: REVENUE, 2018-2020 ($MILLION)
  • FIGURE 66.INTERNATIONAL BUSINESS MACHINES CORPORATION: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 67.INTERNATIONAL BUSINESS MACHINES CORPORATION: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 68.R&D EXPENDITURE, 2019-2021 ($MILLION)
  • FIGURE 69.MCKESSON CORPORATION: REVENUE, 2019-2021 ($MILLION)
  • FIGURE 70.MCKESSON CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 71.R&D EXPENDITURE, 2019-2021 ($MILLION)
  • FIGURE 72.ORACLE CORPORATION: REVENUE, 2019-2021 ($MILLION)
  • FIGURE 73.ORACLE CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 74.ORACLE CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
目次
Product Code: A07488

Healthcare analytics is the process of analyzing healthcare data for predicting various different trends, diseases and even managing the spread of diseases. The field covers a broad range of businesses and offers insights on both the macro and micro level. It can reveal paths to improve patient care quality, clinical data, diagnosis, and business management. In addition to this, various healthcare organizations are using analytics solutions for predicting patients with high risk and providing emergency treatment for the patient, which is driving the growth of the market. Furthermore, healthcare analytics solutions also provide real-time updates that help doctors to deliver better descriptive decisions.

Rise in adoption of big data in healthcare organizations and surge in government initiatives to increase the adoption of electronic health records (EHRs) among healthcare organizations boost the growth of the market. In addition, pressure among the healthcare organizations to curb the unnecessary expenses positively impacts the growth of the market. However, factors such as high implementation cost and lack of skilled labors is expected to hamper the market growth. On the contrary, use of cloud-based analytics across various healthcare providers and rise in adoption of augmented analytics among the healthcare industry is expected to offer remunerative opportunities for the expansion of the market during the forecast period.

The global healthcare analytics market is segmented on the basis of application, component, deployment model, end user, type and region. Depending on application, it is fragmented into financial analysis, operational & administrative analysis and clinical analysis. By component, the market is categorized into hardware software and services. By deployment model, it is bifurcated as on-premise and on-demand. As per end user, the market is categorized into, healthcare payers, healthcare providers and others. On the basis of type, it is classified into descriptive analytics, predictive analytics, and prescriptive analytics. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players profiled in the healthcare analytics market analysis are Allscript Healthcare Solution, Cerner Corporation, Health Catalyst, HMS(Vitreoshealth), IBM Corporation, McKesson Corporation, MedeAnalytics, Inc., Oracle Corporation, Optum, Inc., and SAS, Institute. These players have adopted various strategies to increase their market penetration and strengthen their position in the industry.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global healthcare analytics market forecast along with the current trends and future estimations to explain the imminent investment pockets.
  • Information about key drivers, restraints, & opportunities and their impact analysis on the global market is provided in the report.
  • Porter's five forces analysis illustrates the potency of the buyers and suppliers operating in the industry.
  • The quantitative analysis of the market from 2021 to 2030 is provided to determine the market potential.

Key Market Segments

By Application

  • Financial Analysis
  • Operational & Administrative Analysis
  • Clinical Analysis

By Component

  • Hardware
  • Software
  • Service

By Deployment

  • On-Premise
  • On-Demand

By End User

  • Healthcare Payers
  • Healthcare Providers
  • Other

By Type

  • Descriptive Analytics
  • Predictive Analytics
  • Prescriptive Analytics

By Region

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Australia
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Latin America
  • Middle East
  • Africa

KEY MARKET PLAYERS

  • Allscript Healthcare Solution
  • Cerner Corporation
  • Health Catalyst
  • HMS(Vitreoshealth)
  • IBM Corporation
  • McKesson Corporation
  • MedeAnalytics, Inc.
  • Oracle Corporation
  • Optum, Inc.
  • SAS, Institute

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings
    • 2.1.1.Top impacting factors
    • 2.1.2.Top investment pockets
  • 2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key forces shaping the global Healthcare analytics market
  • 3.3.Market dynamics
    • 3.3.1.Drivers
      • 3.3.1.1.Rise in adoption of big data in healthcare organizations
      • 3.3.1.2.Growing government initiatives to increase the adoption of electronic health records (EHRs) among healthcare organizations
      • 3.3.1.3.Pressure among the healthcare organizations to curb the unnecessary expensive
    • 3.3.2.Restraints
      • 3.3.2.1.High Implementation cost
      • 3.3.2.2.Lack of skilled labors
    • 3.3.3.Opportunities
      • 3.3.3.1.Use of cloud-based analytics across various healthcare providers
  • 3.4.COVID-19 impact analysis on healthcare analytics market
    • 3.4.1.Impact on market size
    • 3.4.2.Consumer trends, preferences, and budget impact
    • 3.4.3.Economic impact
    • 3.4.4.Strategies to tackle negative impact
    • 3.4.5.Opportunity window

CHAPTER 4:HEALTHCARE ANALYTICS MARKET, BY APPLICATION

  • 4.1.Overview
  • 4.2.Financial Analysis
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast, by region
    • 4.2.3.Market analysis, by country
  • 4.3.Operational & Administrative Analysis
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast, by region
    • 4.3.3.Market analysis, by country
  • 4.4.Clinical Analysis
    • 4.4.1.Key market trends, growth factors, and opportunities
    • 4.4.2.Market size and forecast, by region
    • 4.4.3.Market analysis, by country

CHAPTER 5:HEALTHCARE ANALYTICS MARKET, BY COMPONENT

  • 5.1.Overview
  • 5.2.Hardware
    • 5.2.1.Key market trends, growth factors, and opportunities
    • 5.2.2.Market size and forecast, by region
    • 5.2.3.Market analysis, by country
  • 5.3.Software
    • 5.3.1.Key market trends, growth factors, and opportunities
    • 5.3.2.Market size and forecast, by region
    • 5.3.3.Market analysis, by country
  • 5.4.Service
    • 5.4.1.Key market trends, growth factors, and opportunities
    • 5.4.2.Market size and forecast, by region
    • 5.4.3.Market analysis, by country

CHAPTER 6:HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL

  • 6.1.Overview
  • 6.2.On-premise
    • 6.2.1.Key market trends, growth factors, and opportunities
    • 6.2.2.Market size and forecast, by region
    • 6.2.3.Market analysis, by country
  • 6.3.On-Demand
    • 6.3.1.Key market trends, growth factors, and opportunities
    • 6.3.2.Market size and forecast, by region
    • 6.3.3.Market analysis, by country

CHAPTER 7:HEALTHCARE ANALYTICS MARKET, BY END USER

  • 7.1.Overview
  • 7.2.Healthcare Payers
    • 7.2.1.Key market trends, growth factors, and opportunities
    • 7.2.2.Market size and forecast, by region
    • 7.2.3.Market analysis, by country
  • 7.3.Healthcare Providers
    • 7.3.1.Key market trends, growth factors, and opportunities
    • 7.3.2.Market size and forecast, by region
    • 7.3.3.Market analysis, by country
  • 7.4.Others
    • 7.4.1.Key market trends, growth factors, and opportunities
    • 7.4.2.Market size and forecast, by region
    • 7.4.3.Market analysis, by country

CHAPTER 8:HEALTHCARE ANALYTICS MARKET, BY TYPE

  • 8.1.Overview
  • 8.2.Descriptive Analytics
    • 8.2.1.Key market trends, growth factors, and opportunities
    • 8.2.2.Market size and forecast, by region
    • 8.2.3.Market analysis, by country
  • 8.3.Predictive Analytics
    • 8.3.1.Key market trends, growth factors, and opportunities
    • 8.3.2.Market size and forecast, by region
    • 8.3.3.Market analysis, by country
  • 8.4.Prescriptive Analytics
    • 8.4.1.Key market trends, growth factors, and opportunities
    • 8.4.2.Market size and forecast, by region
    • 8.4.3.Market analysis, by country

CHAPTER 9:HEALTHCARE ANALYTICS MARKET, BY REGION

  • 9.1.Overview
    • 9.1.1.Market size and forecast, by region
  • 9.2.North America
    • 9.2.1.Key market trends, growth factors, and opportunities
    • 9.2.2.Market size and forecast, by application
    • 9.2.3.Market size and forecast, by component
    • 9.2.4.Market size and forecast, by deployment model
    • 9.2.5.Market size and forecast, by traditional end user
    • 9.2.6.Market size and forecast, by type
    • 9.2.7.Market size and forecast, by country
      • 9.2.7.1.U.S.
      • 9.2.7.1.1.Market size and forecast, by application
      • 9.2.7.1.2.Market size and forecast, by component
      • 9.2.7.1.3.Market size and forecast, by deployment model
      • 9.2.7.1.4.Market size and forecast, by traditional end user
      • 9.2.7.1.5.Market size and forecast, by type
      • 9.2.7.2.CANADA
      • 9.2.7.2.1.Market size and forecast, by application
      • 9.2.7.2.2.Market size and forecast, by component
      • 9.2.7.2.3.Market size and forecast, by deployment model
      • 9.2.7.2.4.Market size and forecast, by traditional end user
      • 9.2.7.2.5.Market size and forecast, by type
  • 9.3.Europe
    • 9.3.1.Key market trends, growth factors, and opportunities
    • 9.3.2.Market size and forecast, by application
    • 9.3.3.Market size and forecast, by component
    • 9.3.4.Market size and forecast, by deployment model
    • 9.3.5.Market size and forecast, by traditional end user
    • 9.3.6.Market size and forecast, by type
    • 9.3.7.Market size and forecast, by country
      • 9.3.7.1.UK
      • 9.3.7.1.1.Market size and forecast, by application
      • 9.3.7.1.2.Market size and forecast, by component
      • 9.3.7.1.3.Market size and forecast, by deployment model
      • 9.3.7.1.4.Market size and forecast, by traditional end user
      • 9.3.7.1.5.Market size and forecast, by type
      • 9.3.7.2.GERMANY
      • 9.3.7.2.1.Market size and forecast, by application
      • 9.3.7.2.2.Market size and forecast, by component
      • 9.3.7.2.3.Market size and forecast, by deployment model
      • 9.3.7.2.4.Market size and forecast, by traditional end user
      • 9.3.7.2.5.Market size and forecast, by type
      • 9.3.7.3.FRANCE
      • 9.3.7.3.1.Market size and forecast, by application
      • 9.3.7.3.2.Market size and forecast, by component
      • 9.3.7.3.3.Market size and forecast, by deployment model
      • 9.3.7.3.4.Market size and forecast, by traditional end user
      • 9.3.7.3.5.Market size and forecast, by type
      • 9.3.7.4.ITALY
      • 9.3.7.4.1.Market size and forecast, by application
      • 9.3.7.4.2.Market size and forecast, by component
      • 9.3.7.4.3.Market size and forecast, by deployment model
      • 9.3.7.4.4.Market size and forecast, by traditional end user
      • 9.3.7.4.5.Market size and forecast, by type
      • 9.3.7.5.SPAIN
      • 9.3.7.5.1.Market size and forecast, by application
      • 9.3.7.5.2.Market size and forecast, by component
      • 9.3.7.5.3.Market size and forecast, by deployment model
      • 9.3.7.5.4.Market size and forecast, by traditional end user
      • 9.3.7.5.5.Market size and forecast, by type
      • 9.3.7.6.NETHERLANDS
      • 9.3.7.6.1.Market size and forecast, by application
      • 9.3.7.6.2.Market size and forecast, by component
      • 9.3.7.6.3.Market size and forecast, by deployment model
      • 9.3.7.6.4.Market size and forecast, by traditional end user
      • 9.3.7.6.5.Market size and forecast, by type
      • 9.3.7.7.REST OF EUROPE
      • 9.3.7.7.1.Market size and forecast, by application
      • 9.3.7.7.2.Market size and forecast, by component
      • 9.3.7.7.3.Market size and forecast, by deployment model
      • 9.3.7.7.4.Market size and forecast, by traditional end user
      • 9.3.7.7.5.Market size and forecast, by type
  • 9.4.Asia-Pacific
    • 9.4.1.Key market trends, growth factors, and opportunities
    • 9.4.2.Market size and forecast, by application
    • 9.4.3.Market size and forecast, by component
    • 9.4.4.Market size and forecast, by deployment model
    • 9.4.5.Market size and forecast, by traditional end user
    • 9.4.6.Market size and forecast, by type
    • 9.4.7.Market size and forecast, by country
      • 9.4.7.1.CHINA
      • 9.4.7.1.1.Market size and forecast, by application
      • 9.4.7.1.2.Market size and forecast, by component
      • 9.4.7.1.3.Market size and forecast, by deployment model
      • 9.4.7.1.4.Market size and forecast, by traditional end user
      • 9.4.7.1.5.Market size and forecast, by type
      • 9.4.7.2.JAPAN
      • 9.4.7.2.1.Market size and forecast, by application
      • 9.4.7.2.2.Market size and forecast, by component
      • 9.4.7.2.3.Market size and forecast, by deployment model
      • 9.4.7.2.4.Market size and forecast, by traditional end user
      • 9.4.7.2.5.Market size and forecast, by type
      • 9.4.7.3.SOUTH KOREA
      • 9.4.7.3.1.Market size and forecast, by application
      • 9.4.7.3.2.Market size and forecast, by component
      • 9.4.7.3.3.Market size and forecast, by deployment model
      • 9.4.7.3.4.Market size and forecast, by traditional end user
      • 9.4.7.3.5.Market size and forecast, by type
      • 9.4.7.4.AUSTRALIA
      • 9.4.7.4.1.Market size and forecast, by application
      • 9.4.7.4.2.Market size and forecast, by component
      • 9.4.7.4.3.Market size and forecast, by deployment model
      • 9.4.7.4.4.Market size and forecast, by traditional end user
      • 9.4.7.4.5.Market size and forecast, by type
      • 9.4.7.5.INDIA
      • 9.4.7.5.1.Market size and forecast, by application
      • 9.4.7.5.2.Market size and forecast, by component
      • 9.4.7.5.3.Market size and forecast, by deployment model
      • 9.4.7.5.4.Market size and forecast, by traditional end user
      • 9.4.7.5.5.Market size and forecast, by type
      • 9.4.7.6.REST OF ASIA-PACIFIC
      • 9.4.7.6.1.Market size and forecast, by application
      • 9.4.7.6.2.Market size and forecast, by component
      • 9.4.7.6.3.Market size and forecast, by deployment model
      • 9.4.7.6.4.Market size and forecast, by traditional end user
      • 9.4.7.6.5.Market size and forecast, by type
  • 9.5.LAMEA
    • 9.5.1.Key market trends, growth factors, and opportunities
    • 9.5.2.Market size and forecast, by application
    • 9.5.3.Market size and forecast, by component
    • 9.5.4.Market size and forecast, by deployment model
    • 9.5.5.Market size and forecast, by traditional end user
    • 9.5.6.Market size and forecast, by type
    • 9.5.7.Market size and forecast, by country
      • 9.5.7.1.LATIN AMERICA
      • 9.5.7.1.1.Market size and forecast, by application
      • 9.5.7.1.2.Market size and forecast, by component
      • 9.5.7.1.3.Market size and forecast, by deployment model
      • 9.5.7.1.4.Market size and forecast, by traditional end user
      • 9.5.7.1.5.Market size and forecast, by type
      • 9.5.7.2.MIDDLE EAST
      • 9.5.7.2.1.Market size and forecast, by application
      • 9.5.7.2.2.Market size and forecast, by component
      • 9.5.7.2.3.Market size and forecast, by deployment model
      • 9.5.7.2.4.Market size and forecast, by traditional end user
      • 9.5.7.2.5.Market size and forecast, by type
      • 9.5.7.3.AFRICA
      • 9.5.7.3.1.Market size and forecast, by application
      • 9.5.7.3.2.Market size and forecast, by component
      • 9.5.7.3.3.Market size and forecast, by deployment model
      • 9.5.7.3.4.Market size and forecast, by traditional end user
      • 9.5.7.3.5.Market size and forecast, by type

CHAPTER 10:COMPETITIVE LANDSCAPE

  • 10.1.Key players positioning analysis, 2020
  • 10.2.Competitive dashboard
  • 10.3.Top winning strategies

CHAPTER 11:COMPANY PROFILE

  • 11.1.ALLSCRIPTS HEALTHCARE, LLC
    • 11.1.1.Company overview
    • 11.1.2.Key executives
    • 11.1.3.Company snapshot
    • 11.1.4.Operating business segments
    • 11.1.5.Product portfolio
    • 11.1.6.R&D expenditure
    • 11.1.7.Business performance
    • 11.1.8.Key strategic moves and developments
  • 11.2.Cerner Corporation
    • 11.2.1.Company overview
    • 11.2.2.Key Executives
    • 11.2.3.Company snapshot
    • 11.2.4.Product portfolio
    • 11.2.5.Business performance
    • 11.2.6.Key strategic moves and developments
  • 11.3.HEALTH CATALYST
    • 11.3.1.Company overview
    • 11.3.2.Key executives
    • 11.3.3.Company snapshot
    • 11.3.4.Operating business segments
    • 11.3.5.Product portfolio
    • 11.3.6.R&D expenditure
    • 11.3.7.Business performance
    • 11.3.8.Key strategic moves and developments
  • 11.4.HMS(VITREOSHEALTH)
    • 11.4.1.Company overview
    • 11.4.2.Key executive
    • 11.4.3.Company snapshot
    • 11.4.4.Product portfolio
    • 11.4.5.Business performance
  • 11.5.INTERNATIONAL BUSINESS MACHINES CORPORATION
    • 11.5.1.Company overview
    • 11.5.2.Key executive
    • 11.5.3.Company snapshot
    • 11.5.4.Operating business segments
    • 11.5.5.Product portfolio
    • 11.5.6.R&D expenditure
    • 11.5.7.Business performance
    • 11.5.8.Key strategic moves and developments
  • 11.6.MCKESSON CORPORATION
    • 11.6.1.Company overview
    • 11.6.2.Key executives
    • 11.6.3.Company snapshot
    • 11.6.4.Operating business segments
    • 11.6.5.Product portfolio
    • 11.6.6.R&D expenditure
    • 11.6.7.Business performance
    • 11.6.8.Key strategic moves and developments
  • 11.7.MEDEANALYTICS, INC.
    • 11.7.1.Company overview
    • 11.7.2.Key executives
    • 11.7.3.Company snapshot
    • 11.7.4.Product portfolio
    • 11.7.5.Key strategic moves and developments
  • 11.8.OPTUM, INC.
    • 11.8.1.Company overview
    • 11.8.2.Key executives
    • 11.8.3.Company snapshot
    • 11.8.4.Product portfolio
  • 11.9.ORACLE CORPORATION
    • 11.9.1.Company overview
    • 11.9.2.Key Executives
    • 11.9.3.Company snapshot
    • 11.9.4.Operating business segments
    • 11.9.5.Product portfolio
    • 11.9.6.R&D Expenditure
    • 11.9.7.Business performance
    • 11.9.8.Key strategic moves and developments
  • 11.10.SAS INSTITUTE INC.
    • 11.10.1.Company overview
    • 11.10.2.Key executive
    • 11.10.3.Company snapshot
    • 11.10.4.Product portfolio
    • 11.10.5.Key strategic moves and developments